Roka Bioscience raises $60 mln for IPO
Roka Bioscience has launched its IPO after pricing its 5 million shares at $12 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol "ROKA." BofA Merrill Lynch and Leerink Partners are the lead underwriters. Based in Warren, NJ, Roka Bioscience is a molecular diagnostics firm focused on detecting foodborne pathogens. Its backers include OrbiMed Advisors, NEA and TPG Biotech.
17 July 2014•2 mins read
